640 related articles for article (PubMed ID: 28108310)
1. Autophagic dysregulation in doxorubicin cardiomyopathy.
Bartlett JJ; Trivedi PC; Pulinilkunnil T
J Mol Cell Cardiol; 2017 Mar; 104():1-8. PubMed ID: 28108310
[TBL] [Abstract][Full Text] [Related]
2. Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity.
Koleini N; Kardami E
Oncotarget; 2017 Jul; 8(28):46663-46680. PubMed ID: 28445146
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy.
Bartlett JJ; Trivedi PC; Yeung P; Kienesberger PC; Pulinilkunnil T
Biochem J; 2016 Nov; 473(21):3769-3789. PubMed ID: 27487838
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
[TBL] [Abstract][Full Text] [Related]
6. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function.
Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P
J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification.
Li DL; Wang ZV; Ding G; Tan W; Luo X; Criollo A; Xie M; Jiang N; May H; Kyrychenko V; Schneider JW; Gillette TG; Hill JA
Circulation; 2016 Apr; 133(17):1668-87. PubMed ID: 26984939
[TBL] [Abstract][Full Text] [Related]
8. Evidences for the mechanism of Shenmai injection antagonizing doxorubicin-induced cardiotoxicity.
Wu YP; Zhang S; Xin YF; Gu LQ; Xu XZ; Zhang CD; You ZQ
Phytomedicine; 2021 Jul; 88():153597. PubMed ID: 34111614
[TBL] [Abstract][Full Text] [Related]
9. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity.
He L; Liu F; Li J
Cardiovasc Toxicol; 2021 Mar; 21(3):179-191. PubMed ID: 33438065
[TBL] [Abstract][Full Text] [Related]
11. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals.
Smuder AJ; Kavazis AN; Min K; Powers SK
J Appl Physiol (1985); 2013 Jul; 115(2):176-85. PubMed ID: 23703114
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy.
Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J
J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637
[TBL] [Abstract][Full Text] [Related]
14. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
Molecules; 2018 May; 23(5):. PubMed ID: 29762537
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway.
Yin J; Guo J; Zhang Q; Cui L; Zhang L; Zhang T; Zhao J; Li J; Middleton A; Carmichael PL; Peng S
Toxicol In Vitro; 2018 Sep; 51():1-10. PubMed ID: 29729358
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration.
Abdullah CS; Alam S; Aishwarya R; Miriyala S; Bhuiyan MAN; Panchatcharam M; Pattillo CB; Orr AW; Sadoshima J; Hill JA; Bhuiyan MS
Sci Rep; 2019 Feb; 9(1):2002. PubMed ID: 30765730
[TBL] [Abstract][Full Text] [Related]
18. The beneficial role of exercise in mitigating doxorubicin-induced Mitochondrionopathy.
Marques-Aleixo I; Santos-Alves E; Oliveira PJ; Moreira PI; Magalhães J; Ascensão A
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):189-199. PubMed ID: 29408395
[TBL] [Abstract][Full Text] [Related]
19. Inhalation of acidic nanoparticles prevents doxorubicin cardiotoxicity through improvement of lysosomal function.
Santin Y; Formoso K; Haidar F; Fuentes MDPO; Bourgailh F; Hifdi N; Hnia K; Doghri Y; Resta J; Champigny C; Lechevallier S; Détrait M; Cousin G; Bisserier M; Parini A; Lezoualc'h F; Verelst M; Mialet-Perez J
Theranostics; 2023; 13(15):5435-5451. PubMed ID: 37908733
[TBL] [Abstract][Full Text] [Related]
20. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
